TNFSF10 and acute lymphoblastic leukemia: The apparent insensitivity of the PDX and normal thymocytes to TRAIL was consistent with their low level of expression of TRAIL-R2 compared with primary samples from T-ALL patients, which exhibited much higher, although quite variable, TRAIL-R2 expression (Fig. 6B).